ABLY MEDICAL AS: årsregnskap 2023 vs 2022
Grew 79% on revenue, stronger earnings, cash halved-plus
approved 2024-06-26; registry 2024-07-17; journal 2024 636414
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for ABLY MEDICAL AS. Revenue 7.64m NOK → 13.65m NOK (+78.7%). Net result -11.55m NOK → -6.21m NOK. Equity 36.30m NOK → 50.61m NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: cash fell; current ratio dropped below 1×.
Also worth watching: sharp cash drawdown; book investments changed; headcount (årsverk) changed. All figures are taken from the published annual accounts for ABLY MEDICAL AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 7.64m NOK to 13.65m NOK (+78.7% YoY). Calculated
-
↑
Operating result improved
Operating result -10.70m NOK → -5.44m NOK (op. margin -140.0% → -39.8%). Calculated
-
↑
Net result improved
Net result -11.55m NOK → -6.21m NOK (net margin -151.2% → -45.5%). Calculated
-
↑
Equity strengthened
Book equity 36.30m NOK → 50.61m NOK (equity ratio 75.0% → 79.9%). Calculated
-
↑
Owners injected capital
Paid-in equity rose 47.89m NOK → 62.21m NOK (+14.32m NOK). Reported fact
What deteriorated
-
↓
Cash fell
Bank deposits 7.95m NOK → 426.6k NOK (-94.6% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.35× → 0.52× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (7.95m NOK → 426.6k NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Book investments changed
Investment / intangible book value 1.78m NOK → 1.80m NOK. Reported fact
-
·
Headcount (årsverk) changed
Reported FTEs 12 → 13.2. Reported fact